Brief: Doma Perpetual Capital Management Asserts Pacira Biosciences's Board To Pursue Sale Of Company
30/12/2025 15:45
Dec 30 (Reuters) - DOMA PERPETUAL CAPITAL MANAGEMENT: DOMA PERPETUAL CAPITAL MANAGEMENT ANNOUNCES INTENT TO NOMINATE THREE HIGHLY QUALIFIED, INDEPENDENT DIRECTOR CANDIDATES AT 2026 ANNUAL MEETING OF PACIRA BIOSCIENCES, INC. DOMA PERPETUAL CAPITAL MANAGEMENT: ASSERTS PACIRA BIOSCIENCES'S BOARD OF DIRECTORS SHOULD PURSUE AN IMMEDIATE SALE OF COMPANY
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees